Article info
Editorial
Clinicians should think twice before prescribing DPP-4 inhibitors for diabetes
- Correspondence to
: Dr Joshua J Fenton
, Department of Family and Community Medicine, The Center for Healthcare Policy and Research, University of California, Davis Health System, 4860 Y Street, Suite 2300, Sacramento, CA 95817, USA; jjfenton{at}ucdavis.edu
Citation
Clinicians should think twice before prescribing DPP-4 inhibitors for diabetes
Publication history
- Accepted April 3, 2016
- First published April 21, 2016.
Online issue publication
May 23, 2016
Article Versions
- Previous version (21 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/